147 related articles for article (PubMed ID: 37159953)
1. Stepwise Add-On and Endotype-informed Targeted Combination Therapy to Treat Obstructive Sleep Apnea: A Proof-of-Concept Study.
Aishah A; Tong BKY; Osman AM; Pitcher G; Donegan M; Kwan BCH; Brown E; Altree TJ; Adams R; Mukherjee S; Eckert DJ
Ann Am Thorac Soc; 2023 Sep; 20(9):1316-1325. PubMed ID: 37159953
[No Abstract] [Full Text] [Related]
2. Combination therapy with mandibular advancement and expiratory positive airway pressure valves reduces obstructive sleep apnea severity.
Lai V; Tong BK; Tran C; Ricciardiello A; Donegan M; Murray NP; Carberry JC; Eckert DJ
Sleep; 2019 Aug; 42(8):. PubMed ID: 31180512
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
4. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Corser B; Eves E; Warren-McCormick J; Rucosky G
J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
[TBL] [Abstract][Full Text] [Related]
5. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
6. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
7. CPAP combined with oral appliance therapy reduces CPAP requirements and pharyngeal pressure swings in obstructive sleep apnea.
Tong BK; Tran C; Ricciardiello A; Donegan M; Chiang AKI; Szollosi I; Amatoury J; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2020 Nov; 129(5):1085-1091. PubMed ID: 32909921
[TBL] [Abstract][Full Text] [Related]
8. Criteria for oral appliance and/or supine avoidance therapy selection based on outcome optimization and cost-effectiveness.
Levendowski DJ; Olmstead R; Sall E; Westbrook PR; Beine B; Munafo D
J Med Econ; 2021; 24(1):757-763. PubMed ID: 33990168
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA
Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600
[TBL] [Abstract][Full Text] [Related]
10. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
[TBL] [Abstract][Full Text] [Related]
11. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea.
Kushida CA; Chediak A; Berry RB; Brown LK; Gozal D; Iber C; Parthasarathy S; Quan SF; Rowley JA; ;
J Clin Sleep Med; 2008 Apr; 4(2):157-71. PubMed ID: 18468315
[TBL] [Abstract][Full Text] [Related]
12. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of oxygen therapy for patients who do not respond to upper airway surgery for obstructive sleep apnea.
Joosten SA; Tan M; Wong AM; Landry SA; Leong P; Sands SA; Beatty C; Thomson L; Stonehouse J; Turton A; Hamilton GS; Edwards BA
J Clin Sleep Med; 2021 Mar; 17(3):445-452. PubMed ID: 33094725
[TBL] [Abstract][Full Text] [Related]
14. The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.
Combs D; Edgin J; Hsu CH; Bottrill K; Van Vorce H; Gerken B; Matloff D; La Rue S; Parthasarathy S
J Clin Sleep Med; 2023 Dec; 19(12):2065-2073. PubMed ID: 37555595
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.
Messineo L; Taranto-Montemurro L; Calianese N; Gell LK; Azarbarzin A; Labarca G; Vena D; Yang HC; Wang TY; Wellman A; Sands SA
Respirology; 2022 Nov; 27(11):975-982. PubMed ID: 35811347
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea (OSA).
Kryger MH; Berry RB; Massie CA
J Clin Sleep Med; 2011 Oct; 7(5):449-53B. PubMed ID: 22003339
[TBL] [Abstract][Full Text] [Related]
17. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA.
Rosenberg R; Abaluck B; Thein S
J Clin Sleep Med; 2022 Dec; 18(12):2837-2844. PubMed ID: 35975547
[TBL] [Abstract][Full Text] [Related]
18. The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial.
Messineo L; Norman D; Ojile J
J Clin Sleep Med; 2023 Jul; 19(7):1183-1190. PubMed ID: 36805833
[TBL] [Abstract][Full Text] [Related]
19. Long-term obstructive sleep apnea therapy: a 10-year follow-up of mandibular advancement device and continuous positive airway pressure.
Uniken Venema JAM; Doff MHJ; Joffe-Sokolova D; Wijkstra PJ; van der Hoeven JH; Stegenga B; Hoekema A
J Clin Sleep Med; 2020 Mar; 16(3):353-359. PubMed ID: 31992403
[TBL] [Abstract][Full Text] [Related]
20. Comparing the Efficacy, Mask Leak, Patient Adherence, and Patient Preference of Three Different CPAP Interfaces to Treat Moderate-Severe Obstructive Sleep Apnea.
Rowland S; Aiyappan V; Hennessy C; Catcheside P; Chai-Coezter CL; McEvoy RD; Antic NA
J Clin Sleep Med; 2018 Jan; 14(1):101-108. PubMed ID: 29198305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
